United States Ex Rel. Gadbois v. PharMerica Corp.

809 F.3d 1, 93 Fed. R. Serv. 3d 803, 2015 U.S. App. LEXIS 21841, 2015 WL 9093650
CourtCourt of Appeals for the First Circuit
DecidedDecember 16, 2015
Docket14-2164P
StatusPublished
Cited by135 cases

This text of 809 F.3d 1 (United States Ex Rel. Gadbois v. PharMerica Corp.) is published on Counsel Stack Legal Research, covering Court of Appeals for the First Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States Ex Rel. Gadbois v. PharMerica Corp., 809 F.3d 1, 93 Fed. R. Serv. 3d 803, 2015 U.S. App. LEXIS 21841, 2015 WL 9093650 (1st Cir. 2015).

Opinion

SELYA, Circuit Judge.

In this qui tam action, the district court dismissed the claims of the relator, Robert Gadbois, for lack of subject matter jurisdiction. While his appeal of that order *3 was pending, subsequent events coalesced to dissolve the jurisdictional impediment to the relator’s action. He responded to this development by broadening his appeal to include the possibility of supplementing his pleadings. We conclude, as a matter of first impression in this court, that Federal Rule of Civil Procedure 15(d) is available to cure most kinds of defects in subject matter jurisdiction. For prudential reasons, however, we decline to order such supplementation here but, rather, vacate the judgment below to allow the district court to consider the relator’s request for supplementation under Rule 15(d).

I. BACKGROUND

The relator formerly worked as a pharmacist for PharMerica Corp. (PharMeri-ca). In November of 2010, he filed this qui tarn action under seal in the District of Rhode Island. His complaint alleged that PharMerica had committed numerous infractions related to its distribution of prescription drugs to long-term care facilities in violation of the False Claims Act (FCA), 31 U.S.C. §§ 3729-3733, and several parallel state statutes.

The relator filed an amended complaint as of right in May of 2011. More than two years elapsed before the United States elected not to intervene in the case. In short order, the affected states took a similar stance.

The pleadings were unsealed and, in February of 2014, the relator filed a second amended complaint with leave of court. In due course, PharMerica moved to dismiss, asserting both lack of subject matter jurisdiction and failure to state a claim upon which relief could be granted. See Fed.R.Civ.P. 12(b)(1), (6). PharMerica contended, inter alia, that the district court lacked jurisdiction by virtue of the FCA’s first-to-file bar, which provides that if an action involving the same subject matter is already pending, “no person other than the Government may intervene or bring a related action based on the facts underlying the pending action.” 31 U.S.C. § 3730(b)(5). In support of this contention, PharMerica highlighted similarities between the relator’s action and an earlier-filed action that was pending in the United States District Court for the Eastern District of Wisconsin.

The district court, addressing only PharMerica’s request for dismissal under Rule 12(b)(1) and the first-to-file bar, laid the allegations contained in the relator’s second amended complaint alongside the allegations contained in the Wisconsin pleadings. It concluded that the two actions were based on substantially the same facts and conduct. See United States ex rel. Gadbois v. PharMerica Corp., No. 10-471, slip op. at 22-23 (D.R.I. Oct. 3, 2014) (unpublished). Consequently, the court— citing the first-to-file bar — dismissed the relator’s FCA claim for want of subject matter jurisdiction. See id. at 23. It then declined to exercise supplemental jurisdiction over the relator’s state-law claims and dismissed those claims as well. See id.

The relator timely appealed. During the course of briefing, the tectonic plates shifted. First, the Supreme Court handed down its decision in Kellogg Brown & Root Services, Inc. v. United States ex rel. Carter, — U.S. -, 135 S.Ct. 1970, 191 L.Ed.2d 899 (2015), which construed the phrase “pending action” as used in 31 U.S.C. § 3730(b)(5). The Court held that, under the wording of the statute, “an earlier suit bars a later suit, while the earlier suit remains undecided but ceases to bar that suit once it is dismissed.” Id. at 1978. Accordingly, the dismissal of a section 3730(b)(5) claim ordinarily should be without prejudice, because the claim could be refiled once the first-filed action is no longer pending. See id. at 1979.

*4 Less than a month after the Court decided Carter, a second development occurred: the Wisconsin action was settled and dismissed. By then, the relator’s appeal was already partially briefed. Positing that these two developments — the Carter decision and the dismissal of the Wisconsin action — had significantly affected his case, the relator, in his reply brief and by a separate motion to remand, sought to reformulate his complaint on the fly. He requested, in the alternative, that we either deem his complaint supplemented with the additional fact that the Wisconsin action was no longer pending or remand to the district court with instructions to permit him to supplement his complaint under Rule 15(d). In an opposition to the relator’s remand motion and at oral argument, PharMerica argued that neither of these alternatives was appropriate.

II. ANALYSIS

The peculiar posture of this case makes it advisable for us to consider the relator’s procedural arguments first. If the relator’s second amended complaint is a legitimate candidate for supplementation, that would obviate any need to address the degree of similarity between that complaint and the pleadings in the Wisconsin action. Thus, our starting point is the relator’s request for relief under Rule 15(d).

Rule 15(d) affords litigants a pathway for pleading “any transaction, occurrence, or event that happened after the date of the pleading to be supplemented.” The rule shares the core objective of the Civil Rules: “to make pleadings a means to achieve an orderly and fair administration of justice.” Griffin v. Cty. Sch. Bd., 377 U.S. 218, 227, 84 S.Ct. 1226, 12 L.Ed.2d 256 (1964); see Fed.R.Civ.P. 1. Rule 15(d) facilitates this objective by “promoting] as complete an adjudication of the dispute between the parties as is possible.” 6A Charles Alan Wright et al., Federal Practice and Procedure § 1504, at 245 (3d ed.2010); see LaSalvia v. United Dairymen of Ariz., 804 F.2d 1113, 1119 (9th Cir.1986). By the same token, the Rule helps courts and litigants to avoid pointless formality: although causes of action accruing after the institution of a lawsuit usually can be filed as separate actions, supplementation under Rule 15(d) is often a more efficient mechanism for litigating such claims. See Predator Int’l, Inc. v. Gamo Outdoor USA Inc., 793 F.3d 1177, 1186-87 (10th Cir.2015).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Wood v. Yancey, MD
E.D. Virginia, 2025
Tunick v. Takara Sake USA Inc.
N.D. California, 2025
Carter v. Dreesen
D. Nevada, 2025
Michael Melendez v. University of New Hampshire, et al.
2024 DNH 094 (D. New Hampshire, 2024)
Miller v. Tyler Louthan
D. Puerto Rico, 2024

Cite This Page — Counsel Stack

Bluebook (online)
809 F.3d 1, 93 Fed. R. Serv. 3d 803, 2015 U.S. App. LEXIS 21841, 2015 WL 9093650, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-ex-rel-gadbois-v-pharmerica-corp-ca1-2015.